Ep 5. Ketamine

In Drugs, Inc. season 2 episode 5, viewers delve into the world of ketamine, a powerful anesthetic and popular party drug. The episode explores the history of ketamine, including how it was developed as a painkiller in the 1960s and later became an illicit substance popular in the rave scene.

The show also looks at the physical and psychological effects of ketamine, including its ability to induce hallucinations and create dissociative states. Experts weigh in on the dangers of prolonged ketamine use, including potential damage to the bladder and kidneys as well as long-term cognitive impairment.

Through interviews with law enforcement officials, medical professionals, and individuals involved in the ketamine trade, the episode sheds light on how the drug is produced, distributed, and consumed. Viewers are taken on a journey around the world, from clandestine labs in China to nightclubs in the UK, as the show reveals the complex network of suppliers and dealers who profit off of ketamine.

In addition to providing a glimpse into the dark side of drug culture, the episode also explores the potential therapeutic applications of ketamine. Psychiatric professionals are shown administering the drug to patients suffering from depression and anxiety, and discussing the promising results they have seen in alleviating symptoms.

Overall, Drugs, Inc. season 2 episode 5 offers a comprehensive look at the fascinating and complex world of ketamine, from its medical origins to its current status as a popular club drug. By offering perspectives from a variety of sources, the episode encourages viewers to draw their own conclusions about the potential benefits and pitfalls of this powerful substance.